Your browser doesn't support javascript.
loading
MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model.
Bartholomeusz, Chandra; Xie, Xuemei; Pitner, Mary Kathryn; Kondo, Kimie; Dadbin, Ali; Lee, Jangsoon; Saso, Hitomi; Smith, Paul D; Dalby, Kevin N; Ueno, Naoto T.
Afiliação
  • Bartholomeusz C; Section of Translational Breast Cancer Research, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. chbartho@mdanderson.org nueno@mdanderson.org.
  • Xie X; Section of Translational Breast Cancer Research, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pitner MK; Section of Translational Breast Cancer Research, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kondo K; Section of Translational Breast Cancer Research, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dadbin A; Section of Translational Breast Cancer Research, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee J; Section of Translational Breast Cancer Research, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Saso H; Section of Translational Breast Cancer Research, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Smith PD; AstraZeneca, Oncology iMed, Alderley Park, Macclesfield, Cheshire, United Kingdom.
  • Dalby KN; The University of Texas at Austin, Austin, Texas.
  • Ueno NT; Section of Translational Breast Cancer Research, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. chbartho@mdanderson.org nueno@mdanderson.org.
Mol Cancer Ther ; 14(12): 2773-81, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26384399
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Benzimidazóis / MAP Quinase Quinase Quinase 1 / Inibidores de Proteínas Quinases / Neoplasias de Mama Triplo Negativas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Benzimidazóis / MAP Quinase Quinase Quinase 1 / Inibidores de Proteínas Quinases / Neoplasias de Mama Triplo Negativas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article